Cargando…
Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers
OBJECTIVE: Natural killer (NK) cells have gained considerable attention due to their potential in treating “cold tumors,” and are therefore considered as one of the new strategies for curing cancer, by using worldwide development of their new possibilities and interventions with NK cell-related ther...
Autores principales: | Cheng, Ying, Zheng, Xiaodong, Wang, Xuefu, Chen, Yongyan, Wei, Haiming, Sun, Rui, Tian, Zhigang, Sun, Haoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721099/ https://www.ncbi.nlm.nih.gov/pubmed/33299651 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0399 |
Ejemplares similares
-
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
por: Au, Kin Man, et al.
Publicado: (2020) -
A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016) -
Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells
por: Kimura, Kouki, et al.
Publicado: (2023) -
Cytokine-Based Generation of CD49a(+)Eomes(−/+) Natural Killer Cell Subsets
por: Ni, Xiang, et al.
Publicado: (2018) -
Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors
por: Wu, Yang, et al.
Publicado: (2017)